Herpes zoster in the age of focused immunosuppressive therapy

JAMA. 2009 Feb 18;301(7):774-5. doi: 10.1001/jama.2009.150.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy
  • Herpes Zoster / epidemiology
  • Herpes Zoster / etiology*
  • Humans
  • Incidence
  • Neuralgia, Postherpetic / epidemiology
  • Risk Factors
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha